These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30620710)

  • 1. Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies.
    Wang SM; Dowhan DH; Muscat GEO
    J Mol Endocrinol; 2019 Apr; 62(3):R223-R237. PubMed ID: 30620710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
    Al-Hamashi AA; Diaz K; Huang R
    Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
    Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
    Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
    Gao Y; Feng C; Ma J; Yan Q
    Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
    Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
    Elife; 2022 Jan; 11():. PubMed ID: 34984976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
    Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
    Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
    Li WJ; He YH; Yang JJ; Hu GS; Lin YA; Ran T; Peng BL; Xie BL; Huang MF; Gao X; Huang HH; Zhu HH; Ye F; Liu W
    Nat Commun; 2021 Mar; 12(1):1946. PubMed ID: 33782401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.
    Bryant JP; Heiss J; Banasavadi-Siddegowda YK
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PRMT1 and PRMT5 in Breast Cancer.
    Martinez S; Sentis S; Poulard C; Trédan O; Le Romancer M
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Implications of Epigenetic Signaling in Breast Cancer.
    Oh TG; Wang SM; Muscat GE
    Endocrinology; 2017 Mar; 158(3):431-447. PubMed ID: 27983866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and Inhibitors of Histone Arginine Methylation.
    Fulton MD; Brown T; Zheng YG
    Chem Rec; 2018 Dec; 18(12):1792-1807. PubMed ID: 30230223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.
    Shailesh H; Zakaria ZZ; Baiocchi R; Sif S
    Oncotarget; 2018 Nov; 9(94):36705-36718. PubMed ID: 30613353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
    Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
    J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between chromatin remodelers and protein arginine methyltransferases.
    Pal S; Sif S
    J Cell Physiol; 2007 Nov; 213(2):306-15. PubMed ID: 17708529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Protein Arginine Methyltransferases in Pathogenesis and Treatment of Digestive System Carcinoma.
    Wang B; Ding D; Zhang X; Zhang J; Zhang H; Liu X; Chang H; Gao Z; Yu Z
    Mol Cancer Ther; 2023 Aug; 22(8):926-935. PubMed ID: 37141330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review).
    Wu K; Niu C; Liu H; Fu L
    Int J Oncol; 2023 May; 62(5):. PubMed ID: 37026519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy.
    Huang M; Jiang Z; Xu Y; Wu C; Ding W; Meng X; Qian D
    Pharmacol Res; 2024 Oct; 208():107354. PubMed ID: 39154671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
    Hu H; Qian K; Ho MC; Zheng YG
    Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
    Jarrold J; Davies CC
    Trends Mol Med; 2019 Nov; 25(11):993-1009. PubMed ID: 31230909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
    Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
    Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.